Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maze Therapeutics (MAZE) Treasury Shares (2024 - 2025)

Maze Therapeutics' Treasury Shares history spans 2 years, with the latest figure at $10372.0 for Q4 2025.

  • On a quarterly basis, Treasury Shares changed 0.0% to $10372.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $10372.0, a 0.0% change, with the full-year FY2025 number at $10372.0, changed 0.0% from a year prior.
  • Treasury Shares hit $10372.0 in Q4 2025 for Maze Therapeutics, down from $594825.0 in the prior quarter.
  • Over the last five years, Treasury Shares for MAZE hit a ceiling of $594825.0 in Q3 2025 and a floor of $10372.0 in Q4 2024.